$155 Million is the total value of Canaan Partners X LLC's 3 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NXTC | New | NextCure Inc | $253,986,000 | – | 4,508,884 | +100.0% | 82.06% | – |
IDYA | New | IDEAYA Biosciences Inc | $39,910,000 | – | 5,321,426 | +100.0% | 12.90% | – |
ITRM | New | Iterum Therapeutics plc | $15,598,000 | – | 3,466,340 | +100.0% | 5.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-01-27
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
IDEAYA Biosciences Inc | 16 | Q3 2023 | 96.1% |
Iterum Therapeutics plc | 12 | Q3 2022 | 6.0% |
NextCure Inc | 8 | Q3 2021 | 82.8% |
Berkshire Grey Inc | 8 | Q2 2023 | 41.8% |
Astra Space Inc | 4 | Q2 2022 | 51.2% |
MONEYLION INC | 2 | Q3 2023 | 3.9% |
View Canaan Partners X LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-10-11 |
13F-HR | 2023-07-13 |
13F-HR | 2023-04-06 |
13F-HR | 2023-02-01 |
13F-HR | 2022-10-31 |
13F-HR | 2022-08-10 |
13F-HR | 2022-04-28 |
13F-HR | 2022-02-03 |
4 | 2022-01-04 |
13F-HR | 2021-11-15 |
View Canaan Partners X LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.